Related Experiment Video
Updated: May 14, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
The Integrated Stress Response Pathway Coordinates Translational Control of Multiple Immune Checkpoints in Lung
Shayna Thomas-Jardin1, Shruthy Suresh1,2,3, Ariana Arce1
1Department of Molecular Biology, UT Southwestern Medical Center, Dallas, Texas.
Abstract:
The integrated stress response (ISR) is an adaptive pathway hijacked by cancer cells to survive cellular stresses in the tumor microenvironment. ISR activation potently induces PD-L1, leading to suppression of antitumor immunity. In this study, we sought to uncover additional immune checkpoint proteins regulated by the ISR to elucidate mechanisms of tumor immune escape. The ISR coordinately induced cluster of differentiation 155 (CD155) and PD-L1, enhancing translation of both immune checkpoint proteins through bypass of inhibitory upstream open reading frames in their 5' untranslated regions. Analysis of primary human lung tumors identified a significant correlation between expression of PD-L1 and CD155. ISR activation accelerated tumorigenesis and inhibited T-cell function, which could be overcome by combining PD-1 and TIGIT blockade with the ISR inhibitor ISRIB. This study uncovers a mechanism by which two immune checkpoint proteins are coordinately regulated and suggests a therapeutic strategy for patients with lung cancer.
Significance:
The integrated stress response represents a targetable axis to improve the efficacy of immunotherapy in lung cancer by inhibiting the coordinated translational regulation of the PD-L1/PD-1 and CD155/TIGIT immune checkpoint pathways.
Insights
The integrated stress response (ISR) pathway helps cancer cells survive by increasing immune checkpoints like PD-L1 and CD155. Inhibiting ISR may offer a new lung cancer treatment strategy.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Biology
Background:
- The integrated stress response (ISR) is crucial for cancer cell survival in the tumor microenvironment.
- ISR activation promotes tumor immune evasion by inducing Programmed Death-Ligand 1 (PD-L1).
Purpose of the Study:
- To identify additional immune checkpoint proteins regulated by the ISR.
- To elucidate ISR-mediated mechanisms of tumor immune escape.
Main Methods:
- Investigated ISR-coordinated regulation of immune checkpoints.
- Analyzed translation enhancement of PD-L1 and CD155 via 5' UTRs.
- Correlated PD-L1 and CD155 expression in human lung tumors.
Main Results:
- ISR coordinately induced both CD155 and PD-L1 expression.
- Enhanced translation of CD155 and PD-L1 by bypassing upstream open reading frames.
- Found a significant correlation between PD-L1 and CD155 in primary lung tumors.
- ISR activation accelerated tumor growth and impaired T cell function.
Conclusions:
- The ISR coordinates the expression of multiple immune checkpoints, including PD-L1 and CD155.
- Combined blockade of PD-1, TIGIT, and ISR inhibition (ISRIB) can overcome ISR-driven tumor immune escape.
- This study suggests a novel therapeutic strategy for lung cancer targeting the ISR.
More Related Videos
13:37A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
Published on: March 12, 2014
07:39The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
Related Concept Videos
Regulation of the Unfolded Protein Response
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Psychoneuroimmunology: Diabetes and Cancer